The European Commission (@EU_Commission) Industrial R&D Investment Scoreboard 2017/18 comprises of the 2,500 private-sector companies investing the largest sums in research and development in the world.

The Scoreboard includes 154 biopharmaceuticals manufacturers, contributing a total of €138.9 Bn in research and development – approximately 19% of the global estimate.

Twenty-seven drugmakers invested over one billion euros each over 2017/18, totalling €103.5 Bn. Here is a break-down of the key manufacturers in the sector, by investment and profitability.